Theodore H. Stanley, Director at Insys Therapeutics, Inc. (INSY), bought 4,000 shares at $20.99 ($88K) on 2014-05-15, disclosed to the SEC on 2014-05-19.
Open-market purchase of $88k INSY by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.97 | 1,000 | $21K | 23.9% |
| 2 | $20.98 | 1,000 | $21K | 23.9% |
| 3 | $20.99 | 1,000 | $21K | 23.9% |
| 4 | $24.83 | 1,000 | $25K | 28.3% |
| Total | $21.94 avg | 4,000 | $88K | 100% |
| Filing → |
| INSY | SELL | 2016-03-04 | $362K | — | Filing → |
| INSY | SELL | 2015-09-14 | $148K | — | Filing → |
| INSY | SELL | 2015-03-10 | $198K | — | Filing → |